• licensing agreement

George Clinical Partners with Medidata to Unlock Operational Efficiency in Clinical Trials

PRNewswire November 14, 2023

Medidata’s Rave Grants Manager will be implemented across 50 multinational studies and multiple therapeutic areas

SYDNEY, Nov. 14, 2023 /PRNewswire/ — Medidata, a Dassault Systèmes company, announced today that George Clinical, a leading global clinical research organization, is leveraging Medidata’s cloud-based clinical solution Rave Grants Manager. Through this partnership, George Clinical will be able to provide its global clients with a robust, data-driven approach to quickly and accurately develop investigator grant budgets, enhancing operational efficiency and patient recruitment. Additionally, Medidata will also be providing training to ensure seamless adoption and use of the software.

Rave Grants Manager manages the entire investigator grant life cycle of clinical trials. Powered by Medidata’s PICAS database, which contains a large volume of procedures covering most therapeutic indications and phases, the solution provides Sponsors and Contract Research Organization (CROs) with the ability to establish and set fair market value for investigator grant budgets to ensure consistent and accurate budgets. Rave Grants Manager also enables the site budgeting process, and provides tools and data to process site budget amendments.

“George Clinical’s mission is to improve the health of millions of people worldwide through clinical research supported by global service delivery, world-class scientific leadership, and therapeutic expertise. With Medidata Rave Grants Manager, our clients can engage patient populations and reduce sponsor R&D costs, while maintaining the highest scientific integrity,” said Susan Cole, Regional Head Project Operations USA & Europe at George Clinical. 

“Currently, 80% of Sponsors’ time and effort in their financial planning is being consumed by manual processes and workarounds. Rave Grants Manager empowers CROs like George Clinical to make smarter decisions with data-powered financial management for clinical trials. By enhancing operational efficiency, Rave Grants Manager enables sites to spend less time worrying about finances and shift their focus back to the studies and the care of patients,” said Edwin Ng, Senior Vice President, General Manager, Asia Pacific at Medidata Solutions, a Dassault Systèmes company.

Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

About Medidata

Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 2, 000+ customers and partners access the world’s most trusted platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: FR0014003TT8, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE® Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all –consumers, patients and citizens. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com.

©Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries.

Cision View original content:https://www.prnewswire.com/apac/news-releases/george-clinical-partners-with-medidata-to-unlock-operational-efficiency-in-clinical-trials-301986790.html

SOURCE Medidata

AAPR aggregates press releases and media statements from around the world to assist our news partners with identifying and creating timely and relevant news.

All of the press releases published on this website are third-party content and AAP was not involved in the creation of it. Read the full terms.